News & Highlights

from August 2022

The California Institute for Regenerative Medicine (CIRM) approved investing more than $3.8 million in a Phase 1 clinical trial to create a stem cell-based therapy for urethral stricture disease led by Wake Forest University Health Sciences and UCSF Urology, which will serve as the main clinical site. UCSF Urology is a leading center internationally for the treatment and study of urethral stricture disease (https://expertscape.com/ex/urethral+stricture).

Media Contact

Elizabeth Fernandez
UCSF Department of Urology
San Francisco, CA 94143
[email protected]
415/514-1592